Follicular Lymphoma Treatment in India
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is a Follicular Lymphoma?
Follicular lymphoma is a type of B-cell non-Hodgkin lymphoma that develops from abnormal B lymphocytes, a type of white blood cell involved in the immune system. It is generally considered an indolent, or slow-growing, lymphoma, although its behaviour can vary between individuals. Follicular lymphoma commonly affects lymph nodes but can also involve the bone marrow, spleen, and other tissues.
What is the Importance of Timely Treatment?
Timely diagnosis and appropriate management can help determine the extent and biological characteristics of follicular lymphoma and guide treatment decisions. Because many cases grow slowly, immediate treatment is not always necessary. Some patients with asymptomatic, low-burden disease may be monitored through active surveillance, or watchful waiting.
What are the Common Symptoms of Follicular Lymphoma?
- Painless swelling of lymph nodes in the neck, armpit, or groin
- Persistent fatigue or weakness
- Unexplained weight loss
- Fever without an obvious infection
- Drenching night sweats
- Abdominal discomfort or fullness due to an enlarged spleen or lymph nodes
- Recurrent infections in some patients
- Shortness of breath or other symptoms when enlarged lymph nodes affect nearby structures
Causes and Risk Factors of Follicular Lymphoma
Causes
- The exact cause of follicular lymphoma is not fully understood. It develops when genetic changes occur in B lymphocytes, causing them to grow or survive abnormally.
- A characteristic genetic change involving the BCL2 gene on chromosome 18 is commonly associated with follicular lymphoma, although this change alone does not necessarily cause lymphoma.
Risk Factors
- Increasing age
- Certain abnormalities of the immune system
- Immunosuppressive conditions or treatments
- Some autoimmune diseases
- Certain infections or environmental exposures may be associated with lymphoma risk, although their specific role in follicular lymphoma varies
Latest Research and Technologies in the Treatment of Follicular Lymphoma in India
- Treatment of follicular lymphoma has evolved with advances in immunotherapy, targeted therapy, cellular therapy, and molecular diagnostics. Monoclonal antibodies targeting CD20 remain important treatment options. Targeted medicines such as selected PI3K-pathway therapies may be used in specific settings. For patients with relapsed or refractory disease, newer approaches include bispecific antibodies and CAR-T cell therapy, depending on disease characteristics, previous treatments, regulatory approvals, and patient eligibility.
Treatment options for Follicular Lymphoma
Immunotherapy : Anti-CD20 antibodies such as rituximab or obinutuzumab may be used alone or in combination with other treatments.
Cost Start From 1500Explore Options
Chemoimmunotherapy: Chemotherapy combined with an antibody may be considered for patients who require systemic treatment.
Targeted therapy : Targeted medicines may be considered in selected relapsed or refractory cases.
Cost Start From 1000Explore Options
CAR-T cell therapy : For selected patients with relapsed or refractory follicular lymphoma after previous systemic treatments, CAR-T therapy may be considered at specialised centres.
Cost Start From 80000Explore Options
Stem cell transplantation : Autologous stem cell transplantation may be considered in selected patients with relapsed or refractory disease, although its use depends on the clinical situation and availability of newer therapies.
Cost Start From 11500Explore Options
Clinical assessment:
- Detailed medical history and physical examination, including assessment of enlarged lymph nodes, spleen, and other symptoms. Blood tests may evaluate blood cell counts, kidney and liver function, and other relevant markers.
- Tissue biopsy: An excisional or core lymph-node biopsy is generally important to confirm the diagnosis and determine the lymphoma subtype and grade. Immunohistochemistry and other pathological tests help identify characteristic markers.
- Bone marrow evaluation: Bone marrow testing may be considered in selected patients depending on the clinical situation and whether the results will influence staging or treatment.
Imaging Tests:
- PET/CT scan: Helps identify metabolically active lymphoma and assess disease distribution and treatment response.
- CT scan: Can evaluate enlarged lymph nodes and involvement of organs such as the chest, abdomen, and pelvis.
- MRI: May be used when detailed assessment of particular organs or anatomical areas is required.
- Ultrasound: Can help evaluate superficial lymph nodes or abdominal organs in selected cases.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services designed to support Follicular Lymphoma patients in India. These services include:
- Physical activity: Gradual activity can help maintain strength and endurance.
- Physiotherapy: May help with weakness, reduced mobility, or treatment-related physical limitations.
- Nutritional support: Helps maintain adequate calorie and protein intake during treatment.
- Fatigue management: Structured activity, rest, sleep support, and energy conservation strategies can help manage cancer-related fatigue.
- Psychological support: Counselling and supportive-care services may help patients cope with the emotional impact of diagnosis and treatment.
- Medicines used for follicular lymphoma depend on whether the disease is newly diagnosed, symptomatic, relapsed, or refractory. Treatment may include anti-CD20 monoclonal antibodies, chemotherapy, immunomodulatory medicines, targeted therapies, and newer immune-based treatments such as bispecific antibodies. The choice depends on disease characteristics, previous therapies, treatment response, and the patient's overall health.
Instantly Connect with our Specialists
Hospitals for Follicular Lymphoma in India
nanavati Super Speciality Hospital
Mumbai, India
Nanavati Super Speciality Hospital located in Mumbai, India is accredited by NABH. Also listed below are some of the most prominent infrastructural details:
- Capacity of 350 beds
- 75 Critical Care Beds
- 11 Operation Theatres
- 24/7 Catheterization Lab for interventional cardiac services.
- The hospital has a total of 1500 staff with over 350 consultants, 100 resident doctors and 0ver 400 nursing staff.
- Special services to international patients including airport transfer, travel and accommodation booking for attendants, appointments, hospital logistics etc.
Millennium Cancer Center
Gurgaon, India
Millennium Cancer Center is a first of its kind medical center for the research & treatment of cancer in India. The center aims at promoting a knowledge-based cancer care system backed with the latest cancer screening and treatment technology. It provides affordable, accurate, and accessible healthcare to all groups of the society. The hospital has an excellent team of doctors with amazing services, unique infrastructure of international standards in services.
Infrastructure & Facilities:
- Dedicated OPD chambers, Neutropenica Care, and BMT Unit
- Fully equipped intensive care units with the latest monitoring & therapeutic facilities
- In-house 24 X7 blood bank
- All types of in-patient accommodation
- Dedicated neutropenia/leukemia to the special needs of patients
- Hi-tech operation theaters
- Outpatient Chemotherapy Suite to ensure comfort to patients
- An excellent day care cancer centre with state of the art facilities
- Robust IT infrastructure
- State-of-the-art equipped modular operation theatres
- Critical care units equipped with advanced patient monitoring devices, ventilators, isolation rooms
Max Super Speciality Hospital, Patparganj
Delhi, India
Max Super Speciality Hospital, Patparganj, a 400+ bed NABH-accredited facility under Balaji Medical and Diagnostic Research Centre, offers world-class care across 33+ specialties, including Cardiac Sciences, Oncology, Neurosciences, Orthopaedics, Obstetrics & Gynaecology, and Kidney Transplant. With 116 ICU beds, 14 HDU beds, 11 modular OTs, and an NABL-accredited Max Lab, the hospital ensures advanced, quality-driven care. Staffed by 510+ expert doctors and 770+ nurses, it’s India’s first AACI-accredited super speciality hospital and North & West India’s first QAI-accredited Advanced Brain Stroke Centre. Max Patparganj is a regional leader in complex surgeries, blending cutting-edge technology with compassionate, patient-centric healthcare.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose India for Follicular Lymphoma Treatment?
- Experienced hematologist-oncologists: Specialists experienced in lymphoma diagnosis, systemic therapy, and long-term disease management.
- Advanced diagnostic facilities: PET/CT, immunohistochemistry, flow cytometry, cytogenetic and molecular testing can support accurate diagnosis and treatment planning.
- Modern treatment options: Eligible patients may have access to immunotherapy, targeted treatments, bispecific antibodies, and cellular therapies at specialised centres.
- Multidisciplinary care: Haematologists, oncologists, pathologists, radiologists, radiation oncologists, transplant specialists, and supportive-care teams can collaborate on complex cases.
- International patient support: Many hospitals have dedicated international patient services that can assist with medical coordination, documentation, accommodation, travel-related arrangements, and follow-up planning.